Ferrous Fumarate.

Ascorbic acid keeps iron in its reduced, soluble form and binds it into a complex that stays absorbable as gut contents turn less acidic past the stomach, so the body takes up more of the iron in a dose. Pairing vitamin C with non-heme iron is long-standing formulation practice.

Calcium taken in the same sitting competes with iron at the gut wall and lowers how much of the iron dose is absorbed, which is why the two minerals are usually spaced a few hours apart rather than swallowed together.

Copper-dependent ferroxidases such as ceruloplasmin and hephaestin oxidize iron so it can load onto transferrin and move out of the gut and storage into circulation, so the body's normal handling of an iron dose depends on adequate copper.

Zinc and iron share overlapping uptake routes in the gut, so large doses taken together on an empty stomach compete and each is absorbed somewhat less, while taking them with food or at separate times eases the overlap.

Vitamin A status supports the release of stored iron into circulation for red cell formation. When vitamin A is low, the same iron intake delivers less.

Riboflavin-derived FAD supports the reductase step that keeps iron in its absorbable ferrous state and the release of iron from ferritin. Riboflavin status changes how much of an iron dose is used.

Pyridoxal phosphate is the cofactor for ALA synthase, the rate-setting first step of heme synthesis where iron is incorporated. Iron needs the ring built to be used.

Iron fills the heme while B12 supports the DNA synthesis that lets red cell precursors divide. A shortfall in one limits the response to the other.

Folate supplies one-carbon units for the DNA synthesis of dividing red cell precursors, while iron supplies the heme those cells carry. Both are needed for normal red blood cell formation.

Manganese and ferrous iron share the DMT1 transporter at the intestinal brush border, so a large dose of one reduces uptake of the other. Separate them across the day.

Catechins bind non-heme iron in the gut lumen into complexes the transporter cannot take up. This is among the strongest inhibitors of iron absorption from a meal.

Grape seed proanthocyanidins chelate non-heme iron in the lumen and hold it in an unabsorbable form. Co-dosing lowers the iron actually taken up.

Curcumin chelates iron in the gut and in tissue, lowering the amount available for absorption. The interaction moves in the direction of less iron uptake.

Quercetin's catechol groups bind ferrous and ferric iron into poorly absorbed complexes. Dosing it in the same serving reduces iron uptake.

Viscous fibre traps minerals in a gel and slows their release at the absorptive surface. Spacing iron away from a large fibre dose keeps uptake predictable.

Phytate is the main binder of non-heme iron in plant meals, and phytase hydrolyses it and frees that iron. The enzyme raises how much of the same dose is absorbable.

Unbound ferrous iron drives oxidation of membrane fats through Fenton chemistry, and vitamin E is the chain-breaking antioxidant that intercepts it inside membranes. The pairing addresses a known consequence of high-dose ferrous salts.

Non-haem iron salts need an acidic environment to stay in the soluble ferrous state before they reach the absorptive surface of the duodenum. Betaine hydrochloride lowers gastric pH transiently, which keeps more of the dose in solution. The chemistry is settled; the size of the effect on absorbed iron is not quantified in the candidate set.

Anything that raises gastric pH, including bicarbonate and antacid preparations, shifts iron toward the poorly soluble ferric state and reduces how much stays available for uptake. Separating the two by a couple of hours is the standard formulation answer. This is textbook pharmacology and needs no trial to state.

Tannins bind non-haem iron in the gut lumen to form complexes that are not absorbed, which is why tea and coffee taken with an iron dose reduce uptake. The binding is direct and dose-dependent. Timing the iron away from tannin-rich drinks is the practical consequence.

Calcium interferes with non-haem iron uptake at the enterocyte, and a calcium carbonate dose also raises gastric pH, which works against iron solubility at the same time. Both effects push in the same direction. Separating the doses is the usual approach.

Magnesium oxide and magnesium hydroxide act as antacids, raising gastric pH and reducing the fraction of an iron salt that stays soluble. Better-absorbed magnesium forms such as glycinate have far less of this buffering effect. The variable is the magnesium compound, not magnesium as an element.

Cysteine-containing peptides from muscle protein are the long-described meat factor that increases non-haem iron uptake, working by keeping iron in the reduced ferrous state and forming absorbable complexes. That mechanism applies to iron from a fumarate salt as it does to iron from food. It is established pharmacology rather than a tested supplement pairing.

Lactoferrin binds ferric iron tightly and delivers it through a receptor route rather than through DMT1, so it handles iron by a different pathway than an inorganic ferrous salt. Reviews of iron complexes in dairy systems describe protein-bound iron as behaving differently from free salts in both stability and uptake. Whether combining the two adds anything is not measured in the candidate set.

Short-chain fructans ferment quickly in the proximal colon, dropping luminal pH and improving the solubility of mineral ions that escaped the small intestine. The same reasoning applied to calcium is better established than the iron version. Label it as mechanistic support, not a demonstrated increase in iron status.

A large fraction of an oral iron dose is not absorbed and passes into the colon, where it changes the microbial environment, and reviews of oral iron preparations attribute much of the reported digestive discomfort and poor persistence to that unabsorbed load. Probiotics are co-dosed in an attempt to offset the shift. The candidate review describes the tolerability problem, not the solution.

Soluble fibres such as pectin form viscous gels that trap mineral ions in the lumen and slow their contact with the absorptive surface. The effect is partly offset later if the fibre ferments and lowers colonic pH. Separating a large fibre dose from an iron dose is the usual practical answer.

Guar gum raises luminal viscosity substantially at modest doses, which slows the diffusion of dissolved iron toward the brush border. Like other soluble fibres it also ferments in the colon. The net direction depends on dose and timing, so spacing them is the sensible default.

Activated charcoal adsorbs a wide range of compounds in the gut lumen without discriminating between a medicine, a nutrient and a toxin. Taking it near an iron dose removes part of that dose from availability. This is a general rule for charcoal rather than something specific to fumarate.

Amino acids can form soluble chelates with ferrous iron that keep it available as gastric contents move into the less acidic duodenum, and lysine has been examined alongside iron on that basis. The evidence here is small and the mechanism is better established than the outcome. No candidate paper measures this pair.

Glycine is the ligand in iron bisglycinate, where two glycine molecules ring-bind a ferrous ion and shield it from the luminal factors that would otherwise precipitate it or bind it to phytate. That is a different chemical presentation from a fumarate salt, so the two forms behave differently in the gut. Stated as chemistry, not as a recommendation between forms.

Pepsin needs an acidic stomach to work and its peptide products include the cysteine-rich fragments that hold iron in a soluble reduced form. Where gastric acid output is low, both the enzyme and the iron are affected by the same underlying condition. This is a shared dependency rather than a direct interaction.